JPWO2022165362A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022165362A5 JPWO2022165362A5 JP2023546482A JP2023546482A JPWO2022165362A5 JP WO2022165362 A5 JPWO2022165362 A5 JP WO2022165362A5 JP 2023546482 A JP2023546482 A JP 2023546482A JP 2023546482 A JP2023546482 A JP 2023546482A JP WO2022165362 A5 JPWO2022165362 A5 JP WO2022165362A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- composition
- promoter
- sequence
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144408P | 2021-02-01 | 2021-02-01 | |
| US63/144,408 | 2021-02-01 | ||
| PCT/US2022/014601 WO2022165362A2 (en) | 2021-02-01 | 2022-01-31 | Epigenetic gene regulation to treat neurological diseases and pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024505570A JP2024505570A (ja) | 2024-02-06 |
| JP2024505570A5 JP2024505570A5 (https=) | 2025-02-10 |
| JPWO2022165362A5 true JPWO2022165362A5 (https=) | 2025-02-10 |
Family
ID=82653891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546482A Pending JP2024505570A (ja) | 2021-02-01 | 2022-01-31 | 神経学的疾患及び疼痛を治療するためのエピジェネティック遺伝子調節 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240366795A1 (https=) |
| EP (1) | EP4284927A4 (https=) |
| JP (1) | JP2024505570A (https=) |
| CN (1) | CN117203334A (https=) |
| AU (1) | AU2022212277A1 (https=) |
| CA (1) | CA3206936A1 (https=) |
| WO (1) | WO2022165362A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024258906A1 (en) * | 2023-04-17 | 2025-11-06 | Sangamo Therapeutics, Inc. | Zinc finger protein transcription factors for repressing nav1.7 expression |
| US20250057981A1 (en) * | 2023-06-26 | 2025-02-20 | Navega Therapeutics, Inc. | Compositions and methods for reducing pain and inflammation through epigenetic modulation |
| WO2025076459A1 (en) * | 2023-10-05 | 2025-04-10 | Navega Therapeutics, Inc. | Compositions and methods for epigenetic modulation of nav1.7 |
| CN119139498B (zh) * | 2024-09-26 | 2025-11-25 | 武汉泓宸创新生物科技有限公司 | 用于治疗与运动神经元损伤相关的疾病的药物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9624280B2 (en) * | 2013-10-03 | 2017-04-18 | Janssen Biotech, Inc. | Protoxin-II variants and methods of use |
| WO2018035503A1 (en) * | 2016-08-18 | 2018-02-22 | The Regents Of The University Of California | Crispr-cas genome engineering via a modular aav delivery system |
| CA3106446A1 (en) * | 2017-07-13 | 2019-01-17 | University Of Miami | Method for managing pain |
| US20220202957A1 (en) * | 2019-04-09 | 2022-06-30 | The Regents Of The University Of California | Long-lasting analgesia via targeted in vivo epigenetic repression |
-
2022
- 2022-01-31 JP JP2023546482A patent/JP2024505570A/ja active Pending
- 2022-01-31 AU AU2022212277A patent/AU2022212277A1/en active Pending
- 2022-01-31 WO PCT/US2022/014601 patent/WO2022165362A2/en not_active Ceased
- 2022-01-31 CN CN202280022276.2A patent/CN117203334A/zh active Pending
- 2022-01-31 EP EP22746823.8A patent/EP4284927A4/en active Pending
- 2022-01-31 CA CA3206936A patent/CA3206936A1/en active Pending
- 2022-01-31 US US18/274,978 patent/US20240366795A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512649A5 (https=) | ||
| Mietzsch et al. | OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1–12 vectors for gene therapy | |
| Müller et al. | Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors | |
| Xu et al. | Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes | |
| Duan et al. | A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation | |
| Koo et al. | Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice | |
| Recchia et al. | Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector | |
| JP2024099770A5 (https=) | ||
| JPWO2021077000A5 (https=) | ||
| Driskell et al. | Current status of gene therapy for inherited lung diseases | |
| JP2020520643A5 (https=) | ||
| IL283278B1 (en) | Liver-unique promoters and their uses | |
| JP2020522269A5 (https=) | ||
| JP2021505133A5 (https=) | ||
| JPWO2022020616A5 (https=) | ||
| JP2021522836A5 (https=) | ||
| JPWO2019153009A5 (https=) | ||
| JP2024505570A (ja) | 神経学的疾患及び疼痛を治療するためのエピジェネティック遺伝子調節 | |
| JPWO2022165362A5 (https=) | ||
| Sipo et al. | Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction | |
| GB2643476A (en) | Compositions and methods for making epigenetic modifications | |
| CN121925426A (zh) | 肝脏去靶向衣壳 | |
| JPWO2021188729A5 (https=) | ||
| JPWO2020210542A5 (https=) | ||
| Cao et al. | HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production |